Marlene Freeman, MD
Associate Director, Perinatal and Reproductive Psychiatry Clinical Research Program
Massachusetts General Hospital
Professor of Psychiatry
Harvard Medical School
Dr. Marlene Freeman is the Associate Medical Director, Clinical Trials Network & Institute; Director of Clinical Services, Perinatal and Reproductive Psychiatry Program, Massachusetts General Hospital; Professor of Psychiatry, Harvard Medical School. Dr. Freeman completed medical school at Northwestern University Medical School. She completed residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine.
Her research and clinical expertise is in the areas of mood disorders and women's mental health. She established and directed Women's Mental Health Programs at the University of Arizona and the University of Texas Southwestern Medical Center. As a researcher in perinatal psychiatry, she has specific experience working with vulnerable populations. She also has extensive experience in the area of safety, recruitment, and retention of women in clinical trials. She is Vice Editor-in-Chief for The Journal of Clinical Psychiatry.
She is a Distinguished Fellow of the American Psychiatric Association (APA), and chaired the APA Task Force on Complementary and Alternative Medicine, subcommittee on Omega-3 Fatty Acids in Psychiatry, and was a member of the APA's workgroup on Major Depressive Disorder treatment guidelines. She is on the Board of Directors of the American Society of Clinical Psychopharmacology (ASCP) and Postpartum Progress, Inc, and is an Associate Member of the American College of Neuropsychopharmacology (ACNP). She chairs the Membership Advisory Task Force and serves on the Women's Task Force for ACNP.
Marlene P. Freeman, MD
JayMac, Sage; Advisory boards: Otsuka, Alkermes, Sunovion;
Janssen (Johnson& Johnson); Steering Committee for Educational Activities: Medscape.
Dr. Freeman is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry [Current Registry Sponsors: Teva (2018- present), Alkermes, Inc. (2016-Present); Otsuka America Pharmaceutical, Inc. (2008-Present); Forest/Actavis (2016-Present), Sunovion Pharmaceuticals, Inc. (2011-Present)].
As an employee of MGH, Dr. Freeman works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies and NIMH.
Investigator Initiated Trials /Research:
Independent Data Safety and Monitoring Committee:
No financial relationships have been disclosed.